What is the Long-Term Cause of Death in STEMI Patients Treated With Primary PCI?

19.11.20141745
The risk of cardiac mortality declines to less than 1.5 percent per year following survival after a ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI), and noncardiac causes are responsible for the majority of later deaths in these patients, according to a study published Nov. 10 in the Journal of the American College of Cardiology.

The QT Interval Is Associated With Incident Cardiovascular Events: The MESA Study

18.11.20142006
Study Question: Is the baseline QT interval predictive of negative cardiovascular outcomes?

Study Examines Follow-Ups in Adolescents With Family History of Brugada Syndrome

17.11.20141477
В соответствии с исследованием, опубликованным 16 ноября в журнале Американской медицинской ассоциации, у пациентов с семейным анамнезом синдрома Бругада и отрицательным результатом теста, проведенным в детстве, синдром может развиться в последующей жизни в результате действия гормональных, вегетативных или генетических факторов.

Clinical trial will explore bone marrow-derived cell therapy for HF

14.11.20141498
The FDA has accepted an application to begin a phase 3 clinical trial of bone marrow-derived cell therapy for patients with HF, according to a press release from BioCardia Inc.

Long-term weight loss, CV health similar among four popular diets

13.11.20141603
Patients achieved similar but modest weight loss with the Atkins, South Beach, Weight Watchers and Zone diets, according to a systematic review published in Cardiovascular Quality and Outcomes.

CardioBuzz: Update on Antidotes for New Oral Anticoagulants

11.11.20141729
The New England Journal of Medicine reported last week a phase I study of a new drug (PER977, Aripazine) that may be effective as an antidote for several of the new oral anticoagulants, as well as some of the established anticoagulants.

Risk of Bleeding With Dabigatran in Atrial Fibrillation

10.11.20141384
What is the risk of bleeding among Medicare patients with atrial fibrillation (AF) taking dabigatran versus warfarin?
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.